(Total Views: 76)
Posted On: 06/01/2021 10:55:48 AM
Post# of 89360

$PRTK News Article - Paratek Pharmaceuticals Announces FDA Approval of NUZYRA (omadacycline) Oral Only Dosing Regimen for the Treatment of Community-Acquired Bacterial Pneumonia (CABP) https://marketwirenews.com/news-releases/para...73540.html


My Twitter: WhyteStocks